#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Solitary fibrous tumour Gastrointestinal disorder Basal cell naevus syndrome Autoimmune disorder Pulmonary alveolar haemorrhage Still's disease Aicardi-Goutieres syndrome Von Willebrand's disease Pemphigoid Biliary neoplasm MELAS syndrome Superficial vein thrombosis Osteosarcoma metastatic Angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Basic Information Lennox-Gastaut syndrome Pemphigus – Treatment Andersen-Tawil syndrome – Basic Information Hepatoblastoma – Life with Disease Mucopolysaccharidosis III – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Primary biliary cholangitis – Treatment Lymphangiosarcoma – Diagnostics Gaucher’s disease type III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xxb750 Prucalopride Spiramycin Edg-5506 Timrepigene Emparvovec Fluorometholone Sodium Chloride Ph. Eur. HYALURONIDASE Technetium (99Mtc) DESMOPRESSIN ACETATE Gremubamab Rintatolimod Bleomycin Sulfate Bemcentinib Azithromycin Dihydrate Micafungin Darunavir Epcoritamab Int-787 Morphine Hydrochloride More therapies…

    Learn about Your Condition

    Peripheral artery angioplasty Ventricular tachycardia Vulval cancer Alopecia areata Vesicoureteric reflux Polymyalgia rheumatica Skin bacterial infection Macular degeneration Undifferentiated sarcoma Gastrointestinal melanoma Hyperkalaemia Cardiovascular disorder Procedural haemorrhage Ectopic pregnancy Liver disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Esketamine Nasal Spray for Patients with Treatment-Resistant Bipolar Depression

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Esketamine
    The Netherlands

  • Study of Durvalumab for Patients with Early Stage or Locally Advanced Non-Small Cell Lung Cancer Not Suitable for Surgery

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Portugal

  • Study on Aldesleukin and Dendritic Cell Vaccine for Patients with Resected Stage IV Neuroendocrine Tumors and Soft Tissue Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Soft tissue sarcoma
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Aldesleukin
    Italy

  • Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Neoplasm malignant
    Investigated Drugs:
    • 68Ga-Nota-Abscint-Her2
    Austria Belgium

  • Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer’s, Parkinson’s, or ALS Using Dronabinol and Cannabidiol

    Recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    • Amyotrophic lateral sclerosis
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Italy

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Berotralstat
    Czechia France Germany Italy Poland Slovakia +1
Previous Page
1 … 312 313 314 315 316 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!